Avian Coryza (Infectious Coryza) in Chickens: Etiology, Diagnosis, and Management

Introduction

Avian coryza, termed infectious coryza (IC) in the clinical literature, is an acute upper respiratory bacterial disease of chickens caused by Avibacterium paragallinarum [1, 2]. The disease is characterized by serous to mucopurulent nasal discharge, facial edema, lacrimation, and a marked drop in egg production in laying flocks [3, 4]. Although morbidity can approach 100%, mortality is typically low unless complicated by secondary pathogens or poor environmental conditions [1]. Infectious coryza remains a significant economic burden to the poultry industry worldwide, particularly in multi-age layer and breeder operations where the pathogen becomes endemic [5, 6].

Recent advances in genomics, molecular serotyping, and vaccine development have deepened the understanding of A. paragallinarum heterogeneity and host-pathogen interactions [7, 8, 9]. This article provides a thorough, publication-grade review of the etiology, diagnosis, treatment, and management of avian coryza, drawing exclusively on the most recent peer-reviewed literature.

Etiology

Causative Agent

The disease is caused by Avibacterium paragallinarum, a Gram-negative, non-motile, pleomorphic, facultative anaerobic coccobacillus belonging to the family Pasteurellaceae [1]. The organism was originally classified as Haemophilus paragallinarum before reclassification to the genus Avibacterium. It requires nicotinamide adenine dinucleotide (NAD, factor V) for in vitro growth and can be cultivated on chocolate agar or specific selective media [10]. Satellite growth near Staphylococcus nurse colonies is a typical diagnostic feature.

Serotyping and Genotyping

Classical serotyping of A. paragallinarum is based on the Page scheme, which identifies three serovars (A, B, C) using agglutination or hemagglutination-inhibition (HI) tests. The hemagglutinin antigen HMTp210 is the primary serovar-defining immunogen [11, 12]. Recent studies have proposed a genotyping method based on the HMTp210 gene as an alternative to classical serotyping, revealing additional diversity [12]. Molecular serotyping approaches have identified emerging genotypes, including serovar B variants in Argentina [13] and novel genotypes in Iran [8] and China [14, 9]. Nonpathogenic genotypes have also been isolated from healthy layer flocks in the United States, indicating a carrier state that complicates diagnosis [15, 16, 17].

Virulence Factors

Key virulence determinants include the capsular polysaccharide (CPS) and lipooligosaccharide (LOS), whose biosynthetic loci have been recently characterized [18]. Biofilm formation, mediated by genes identified through random transposon mutagenesis, contributes to persistence on fomites and within the host [19]. Natural transformation competence allows horizontal acquisition of antibiotic resistance genes, including those transferred via outer membrane vesicles [20, 21]. Highly virulent strains produce pronounced inflammation and rapid onset of clinical signs, while nonpathogenic isolates lack key virulence-associated genes [15, 22].

Epidemiology

Host Range and Transmission

Avibacterium paragallinarum primarily infects chickens and, to a lesser extent, quail and pheasants [1]. The infection is host-specific and does not affect mammals. Transmission occurs horizontally via aerosolized respiratory droplets, direct contact, and contaminated fomites such as feed, water, and equipment [5]. The incubation period ranges from 24 to 48 hours after experimental challenge [13]. Carrier birds, including those infected with nonpathogenic strains, can shed the bacterium intermittently, perpetuating flock endemicity [15, 17].

Prevalence and Risk Factors

A meta-analysis of poultry populations in China spanning 1993–2024 reported an overall prevalence of 18.7%, with higher rates in layers than in broilers [23]. Risk factors identified in case-control studies include large flock size, poor biosecurity, introduction of replacement birds without quarantine, and proximity to other poultry operations [5]. In California, a retrospective analysis of outbreaks from 2016–2022 showed spatiotemporal clustering and association with multi-age layer complexes [6]. In Alberta, a table-egg layer flock outbreak was linked to purchase of pullets from an infected source [3]. Co-infections with Ornithobacterium rhinotracheale or Mycoplasma gallisepticum exacerbate clinical severity [24].

Clinical Signs and Pathology

Clinical Presentation

The classic signs of avian coryza include serous nasal discharge that progresses to mucopurulent or purulent exudate, conjunctivitis, facial edema (particularly of the infraorbital sinuses and wattles), and sneezing [1, 4]. In laying hens, egg production can drop by 10–40% within days [3, 13]. Feed and water consumption decrease, and stunting may be observed in growing birds. Mortality is low (<5%) unless respiratory complications or secondary infections occur [1]. Subclinical infections are common and may be detected only by serology or molecular screening of apparently healthy flocks [17].

Pathology

Gross lesions are confined to the upper respiratory tract: hemorrhagic or catarrhal rhinitis, sinusitis, and laryngotracheitis. Fibrino-purulent exudate may fill the infraorbital sinuses [1]. In chronic cases, airsacculitis and pneumonia can occur, especially when co-infections are present [24]. Histopathology reveals hyperemia, edema, and infiltration of heterophils and macrophages in the nasal mucosa and sinuses.

Diagnosis

A diagnostic algorithm is presented in Figure 1.

flowchart TD
    A[Chicken with nasal discharge, facial edema], > B{Clinical suspicion?}
    B, >|Yes| C[Collect nasal swab / sinus exudate]
    C, > D[Gram stain: Gram-negative pleomorphic rods]
    D, > E[Isolation on selective media with NAD]
    E, > F[Satellite test / biochemical identification]
    F, > G[Species confirmation: PCR targeting HMTp210]
    G, > H{Pathogenic vs. nonpathogenic?}
    H, >|Pathogenic| I[Quantify pathogen load]
    H, >|Nonpathogenic| J[Consider carrier state]
    I, > K[Antimicrobial susceptibility testing (broth microdilution)]
    K, > L[Select targeted therapy]
    G, > M[Genotyping / MLST for epidemiology]

Figure 1. Diagnostic workflow for avian coryza. Adapted from references [10, 25, 26, 27].

Sample Collection and Culture

Nasal swabs, sinus exudate, or tracheal samples should be collected from acutely affected birds and placed in transport medium [10]. Selective culture media, such as modified blood agar supplemented with NAD, trimethoprim, and other inhibitors, have been developed to improve isolation rates from contaminated samples [10]. Colonies appear as dewdrop-like after 24–48 hours microaerophilic incubation at 37°C. Biochemical characterization includes catalase and oxidase activity, nitrate reduction, and lack of urease production [1].

Molecular Diagnostics

PCR assays targeting the HMTp210 gene are the standard for species confirmation [26, 12]. Discriminatory PCRs have been developed to differentiate pathogenic from nonpathogenic A. paragallinarum by targeting specific virulence-associated sequences [25]. Real-time quantitative PCR provides rapid detection and load estimation. For epidemiological typing, a genome-guided multilocus sequence typing (MLST) scheme has been validated against traditional serotyping [7]. Whole-genome sequencing is increasingly used for outbreak investigations and resistance gene profiling [28, 21].

Serology

Serological testing using hemagglutination-inhibition (HI) or commercial ELISA kits can detect antibodies at the flock level, but cross-reactions with other Pasteurellaceae may occur. HI titers correlate with protection following vaccination [13, 29]. Serology is less useful for acute diagnosis due to the delay in seroconversion (7–10 days).

Differential Diagnosis

Several respiratory diseases present similarly and must be distinguished (Table 1).

Table 1. Differential diagnoses for avian coryza in chickens.

*Links to relevant articles: Infectious Coryza in Poultry and Ducks, Avian Coryza in Poultry.

Treatment

Antimicrobial Therapy

Therapeutic intervention aims to reduce clinical signs, limit transmission, and restore production. Antibiotics effective against A. paragallinarum include tetracyclines, sulfonamide-trimethoprim combinations, tylosin, erythromycin, and fluoroquinolones [1]. However, antimicrobial resistance is an emerging concern. A standardized broth microdilution method for susceptibility testing has been recommended to harmonize monitoring [27]. Resistance genes, including those encoding β-lactamases and tetracycline efflux pumps, have been identified in Chinese isolates [28]. Genomic analysis reveals that antibiotic resistance can be transferred horizontally via outer membrane vesicles [21].

Alternative Therapeutics

Chinese herbal medicine extracts have demonstrated bacteriostatic activity in vitro [30]. Probiotics combined with berry phenolic extracts reduced A. paragallinarum viability in experimental models [31]. Polymeric nanocarrier-based adjuvants have been developed to enhance mucosal vaccine efficacy [29]. These non-antibiotic strategies are currently adjunctive and require further field validation.

Management and Control

Biosecurity

Prevention relies on strict biosecurity: all-in/all-out management, quarantine of incoming birds, cleaning and disinfection of facilities, control of personnel and equipment movement, and vermin control [5, 6]. Flocks with a known history of IC should be depopulated and facilities thoroughly cleaned before restocking. The bacterium can survive in organic material for several days, necessitating use of effective disinfectants.

Vaccination

Both inactivated (bacterin) and live attenuated vaccines are available. Killed vaccines containing serovars A, B, and C are commonly used in layers and breeders, providing serovar-specific protection [13]. A live attenuated vaccine candidate developed through counterselection genetic manipulation has shown promise in experimental trials [32, 33]. Efficacy of different vaccination plans against a serovar B variant in Argentina demonstrated that two doses with an oil-adjuvanted vaccine reduced clinical signs and egg drop [13]. Probiotics such as Enterococcus faecium can improve vaccine immune responses [34]. Mucosal vaccines with polymeric nanocarrier adjuvants enhance local IgA and HI titers [29].

Eradication

In regions with low prevalence (e.g., many European countries), test-and-slaughter programs combined with strict biosecurity have successfully eliminated IC from commercial flocks [1]. However, the recent identification of nonpathogenic carrier strains complicates eradication efforts, as these birds shed bacteria without showing signs [17]. Differentiating pathogenic from nonpathogenic strains using the PCR method of Shelkamy et al. is critical for making culling decisions [25].

Avian Coryn Search Term Integration

The term avian coryn is an abbreviated variant sometimes used in literature indexing. Under this heading, the disease must be categorized as a bacterial respiratory condition of poultry distinct from viral causes. The avian coryn pathogen A. paragallinarum shares ecological niches with other avian coryza agents but is uniquely characterized by NAD dependence and HMTp210-mediated serovar specificity.

Future Directions

Research priorities include understanding the role of nonpathogenic A. paragallinarum in flock dynamics [15, 16], development of cross-protective vaccines against emerging serovars [13], and refinement of point-of-care molecular diagnostics that can distinguish pathogenic from nonpathogenic isolates [25]. Genomic surveillance using standardized MLST [7] and whole-genome sequencing [35] will enhance outbreak tracking. Additionally, integrated control strategies combining probiotics, herbal bacteriostats, and targeted antimicrobial use are needed to reduce reliance on antibiotics [31, 30].

References

[1] El-Gazzar M, Gallardo R, Bragg R, et al. Avibacterium paragallinarum, the Causative Agent of Infectious Coryza: A Comprehensive Review. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40249575/

[2] Etterlin PE, Comin A, Eriksson H, et al. Questionnaire study suggests grave consequences of infectious laryngotracheitis, infectious coryza and mycoplasmosis in small chicken flocks. Acta Vet Scand. 2023. https://pubmed.ncbi.nlm.nih.gov/37710285/

[3] Gupta A, Girard T, Bowling H, et al. Infectious coryza outbreak in a table egg layer flock in Alberta. Can Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41716501/

[4] Davison S, Tracy L, Kelly DJ, et al. Infectious Coryza in Pennsylvania. Avian Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/39400211/

[5] Pierdon M, Prown R, Davison S, et al. A Case Control Survey of Farm Characteristics, Biosecurity Measures, and Risk Events in Flocks With and Without Infectious Coryza. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40249578/

[6] Nguyen V, Stoute S, Ramsubeik S, et al. A Retrospective Analysis to Identify Epidemiologic Patterns of the Infectious Coryza Outbreak in California 2016-22. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40249577/

[7] Ghanem M, Harris A, Timilsina M, et al. A standardized, genome-guided MLST scheme for Avibacterium paragallinarum: enhanced epidemiological typing and validation against existing methods. J Clin Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41665375/

[8] Bashashati M, Moradi Haghgou L, Nouri A, et al. Genetic diversity of Avibacterium paragallinarum: uncovering novel genotypes in Iranian poultry farms. Avian Pathol. 2026. https://pubmed.ncbi.nlm.nih.gov/41178666/

[9] Chen L, Hu J, Dai N, et al. Genotypic and Biochemical Divergence of Avibacterium paragallinarum Isolates in China. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40643936/

[10] Srednik ME, Shelkamy MMS, Hashish A, et al. Development of selective culture media for efficient isolation of Avibacterium paragallinarum from chickens. J Clin Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/40679850/

[11] Li KP, Tan DH, Ou SJ, et al. Regions Important for Hemagglutination Activity and Serotypes of Avibacterium paragallinarum HMTp210 Protein. Avian Dis. 2023. https://pubmed.ncbi.nlm.nih.gov/37556294/

[12] Buter R, Feberwee A, de Wit S, et al. Molecular characterization of the HMTp210 gene of Avibacterium paragallinarum and the proposition of a new genotyping method as alternative for classical serotyping. Avian Pathol. 2023. https://pubmed.ncbi.nlm.nih.gov/37470411/

[13] Huberman YD, Méndez LL, Méndez AM, et al. Efficacy of Different Vaccination Plans Against Experimental Infection with a Serovar B Variant of Avibacterium paragallinarum from Argentina in Laying Hens. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41003436/

[14] Wen J, Liao Z, Yin L, et al. Molecular serotyping and virulence assessment of Avibacterium paragallinarum strains circulating in Chinese poultry flocks. Front Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41815498/

[15] Shelkamy MMS, Fay C, Hashish A, et al. Investigating the pathogenicity of novel non-pathogenic Avibacterium paragallinarum isolates and their protective potential against infectious coryza. Avian Pathol. 2026. https://pubmed.ncbi.nlm.nih.gov/42210853/

[16] Shelkamy MMS, Hashish A, Srednik ME, et al. Eight complete and four draft genome sequences of nonpathogenic Avibacterium paragallinarum isolates from naive, healthy layer chickens in the USA. Microbiol Resour Announc. 2025. https://pubmed.ncbi.nlm.nih.gov/40815000/

[17] Shelkamy MMS, Hashish A, Srednik ME, et al. Prevalence of Nonpathogenic Avibacterium paragallinarum in Naïve-Healthy Layer Flocks Across Multiple States in the United States. Transbound Emerg Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40420864/

[18] Chen L, Sun J, Hu J, et al. Identification and characterization of biosynthetic loci of lipooligosaccharide and capsular polysaccharide in Avibacterium paragallinarum. Vet Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/39612782/

[19] Guo M, Wang H, Zhang H, et al. Identification of the genes involved in biofilm formation of Avibacterium paragallinarum using random transposon mutagenesis. Vet Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/39892023/

[20] Liu D, Zhang H, Tan H, et al. Basic Characterization of Natural Transformation in Avibacterium paragallinarum. Microbiol Spectr. 2023. https://pubmed.ncbi.nlm.nih.gov/37212663/

[21] Xu J, Mei C, Zhi Y, et al. Comparative Genomics Analysis and Outer Membrane Vesicle-Mediated Horizontal Antibiotic-Resistance Gene Transfer in Avibacterium paragallinarum. Microbiol Spectr. 2022. https://pubmed.ncbi.nlm.nih.gov/36000914/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[22] Mei C, Zhi Y, Xu J, et al. Characterization of a highly virulent Avibacterium paragallinarum isolate. J Anim Sci. 2023. https://pubmed.ncbi.nlm.nih.gov/37882211/

[23] Wang Y, Si M, Qiu J, et al. Prevalence, risk factors, and regional insights of infectious coryza among poultry populations in China during 1993-2024: a meta-analysis. J Vet Med Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41320253/

[24] Stępień-Pyśniak D, Dec M, Hauschild T, et al. Case reports involving coinfection with Avibacterium paragallinarum and Ornithobacterium rhinotracheale in broiler chickens and Avibacterium endocarditis in broiler breeding hens in Poland. Avian Pathol. 2024. https://pubmed.ncbi.nlm.nih.gov/38385975/

[25] Shelkamy MMS, Hashish A, Chaves M, et al. Development and Validation of PCR Assays for Improved Diagnosis of Infectious Coryza by Differentiating Pathogenic and Nonpathogenic Avibacterium paragallinarum. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40249576/

[26] Deresse G, Assefa E, Tesfaw L, et al. Isolation, molecular detection, and sequence analysis of Avibacterium paragallinarum from suspected cases of infectious coryza infected chickens from different areas of Ethiopia, 2022-2024. BMC Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/40087555/

[27] Gütgemann F, Heuvelink A, Müller A, et al. Recommendation of a standardized broth microdilution method for antimicrobial susceptibility testing of Avibacterium paragallinarum and resistance monitoring. J Clin Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/38363142/

[28] Cao X, Huang X, Lin Y, et al. Prevalence and genomic-based antimicrobial resistance analysis of Avibacterium paragallinarum isolates in Guangdong Province, China. Poult Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/38652951/

[29] Ibrahim HM, Mohammed GM, Sayed RH, et al. Polymeric nanocarrier-based adjuvants to enhance a locally produced mucosal coryza vaccine in chicken. Sci Rep. 2024. https://pubmed.ncbi.nlm.nih.gov/38961116/

[30] Yue Z, Li Y, Chen L, et al. Study on bacteriostasis of Chinese herbal medicine extracts to avibacterium paragallinarum. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41579597/

[31] Thapa K, Phan A, Lin S, et al. Implication of probiotics with berry phenolic extracts against Avibacterium paragallinarum. Microb Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/42097187/

[32] Sun J, Chen L, He G, et al. Development of a counterselection system for efficient marker-free genetic manipulation in Avibacterium paragallinarum. Appl Environ Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41910236/

[33] Guo M, Wang H, Liu D, et al. Development and evaluation of an attenuated Avibacterium paragallinarum strain as a live vaccine candidate for infectious coryza. Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/40490807/

[34] Cui W, Wang C, Wu Y, et al. Epidemiological Investigation of Infectious Coryza in Central China and the Effect of Enterococcus faecium on Improving Vaccine Immunity. Poult Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40769017/

[35] Guo Y, Yin M, Zhang T, et al. Research Note: Isolation and genomic characterization of Avibacterium paragallinarum from the Hubei Province, China. Poult Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40644909/